BNB Plus Corp.
- BNBX
- NASDAQ
- Biotechnology
- DNA/RNA Synthesis
- Nucleic Acid Technologies
$0.16
Quote Jul 13, 2026, 08:00 PM UTC
−62.85%over the last month
Max drawdown −78.8%From 1-month high −62.9%3 months −71.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.0M
Quote Jul 13
Next earnings
—
Data unavailable
Latest analyst target
—
Data unavailable
Floor
$0.14
14.1% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BNBXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q1 2026 revenue $1.1M
- Product$555,09349.5%
- Large Scale DNA Production$423,01037.8%
- Supply Chain$113,58210.1%
- Research and Development Services (Over-Time)$28,8022.6%
Industry
Biotechnology
Employees
26